FDA Grants Full Approval to Blinatumomab for Acute Lymphoblastic Leukemia

News   Jul 27, 2017 | Original story from NIH

 
FDA Grants Full Approval to Blinatumomab for Acute Lymphoblastic Leukemia

Credit: Christaras A, CC BY 2.5

 
 
 

RELATED ARTICLES

A Carcinogen at the Gym

News

Gyms are places people go to get healthier. But nearly half the gyms in the U.S. contain a potentially addictive carcinogen - tanning beds, report UConn researchers.

READ MORE

A Mechanism of Drug Resistance in Breast & Ovarian Cancer

News

Researchers have discovered the molecular means by which some cancers caused by errors in the gene BRCA1 evade treatment by drugs custom-tailored to kill them.

READ MORE

Novel Therapeutic Target for Breast Cancer

News

Research has shown for the first time that a tiny piece of RNA deregulates energy metabolism, an emerging hallmark of cancer. The finding identifies a new target for therapeutic intervention in breast cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy